Immunotherapy in the adjuvant setting for high-risk melanoma
Clin Adv Hematol Oncol
.
2018 Aug;16(8):546-548.
Author
Jeffrey S Weber
1
Affiliation
1
NYU School of Medicine, New York, New York.
PMID:
30148825
No abstract available
Publication types
Review
MeSH terms
Chemotherapy, Adjuvant / methods
Humans
Melanoma* / diagnosis
Melanoma* / genetics
Melanoma* / pathology
Melanoma* / therapy
Risk Factors